Yu‐Ning Teng

432 total citations
20 papers, 333 citations indexed

About

Yu‐Ning Teng is a scholar working on Oncology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Yu‐Ning Teng has authored 20 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Molecular Biology and 3 papers in Infectious Diseases. Recurrent topics in Yu‐Ning Teng's work include Drug Transport and Resistance Mechanisms (14 papers), Natural product bioactivities and synthesis (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). Yu‐Ning Teng is often cited by papers focused on Drug Transport and Resistance Mechanisms (14 papers), Natural product bioactivities and synthesis (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). Yu‐Ning Teng collaborates with scholars based in Taiwan, United States and China. Yu‐Ning Teng's co-authors include Chin‐Chuan Hung, Yow‐Wen Hsieh, Yu‐Hsuan Lan, Charles C. N. Wang, Ming‐Jyh Sheu, Yao‐Chang Chiang, Hui‐Yi Lin, Kuo‐Hsiung Lee, Susan L. Morris‐Natschke and Chieh-Liang Huang and has published in prestigious journals such as PLoS ONE, Journal of Agricultural and Food Chemistry and Scientific Reports.

In The Last Decade

Yu‐Ning Teng

17 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu‐Ning Teng Taiwan 11 194 131 53 33 31 20 333
Sylwia Borska Poland 12 233 1.2× 84 0.6× 37 0.7× 40 1.2× 34 1.1× 19 412
Riham Salah El-Dine Egypt 8 171 0.9× 144 1.1× 54 1.0× 19 0.6× 17 0.5× 10 386
Kee Wee Tan China 8 204 1.1× 137 1.0× 49 0.9× 23 0.7× 13 0.4× 13 413
Gowtham Kumar Subbaraj India 11 177 0.9× 51 0.4× 38 0.7× 36 1.1× 8 0.3× 60 444
Andrea Čumová Czechia 7 205 1.1× 88 0.7× 41 0.8× 28 0.8× 24 0.8× 10 406
Narendra Joshi India 9 165 0.9× 67 0.5× 22 0.4× 51 1.5× 27 0.9× 17 363
Isabel Moreira da Silva Portugal 9 281 1.4× 103 0.8× 26 0.5× 19 0.6× 8 0.3× 22 602
Yasmeen M. Attia Egypt 13 173 0.9× 103 0.8× 20 0.4× 34 1.0× 13 0.4× 25 432
Yiyi Ye China 11 205 1.1× 86 0.7× 60 1.1× 27 0.8× 17 0.5× 17 396
Shu‐Yi Yin Taiwan 9 220 1.1× 77 0.6× 65 1.2× 36 1.1× 59 1.9× 15 573

Countries citing papers authored by Yu‐Ning Teng

Since Specialization
Citations

This map shows the geographic impact of Yu‐Ning Teng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Ning Teng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Ning Teng more than expected).

Fields of papers citing papers by Yu‐Ning Teng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Ning Teng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Ning Teng. The network helps show where Yu‐Ning Teng may publish in the future.

Co-authorship network of co-authors of Yu‐Ning Teng

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Ning Teng. A scholar is included among the top collaborators of Yu‐Ning Teng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Ning Teng. Yu‐Ning Teng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
5.
Chen, Jia‐Shing, et al.. (2023). A novel STAT3/ NFκB p50 axis regulates stromal-KDM2A to promote M2 macrophage-mediated chemoresistance in breast cancer. Cancer Cell International. 23(1). 237–237. 4 indexed citations
6.
7.
8.
9.
10.
Teng, Yu‐Ning, et al.. (2021). Cinnamophilin overcomes cancer multi-drug resistance via allosterically modulating human P-glycoprotein on both drug binding sites and ATPase binding sites. Biomedicine & Pharmacotherapy. 144. 112379–112379. 8 indexed citations
11.
12.
Teng, Yu‐Ning, et al.. (2020). Caffeic Acid Attenuates Multi-Drug Resistance in Cancer Cells by Inhibiting Efflux Function of Human P-Glycoprotein. Molecules. 25(2). 247–247. 40 indexed citations
13.
Teng, Yu‐Ning, et al.. (2019). Danazol mediates collateral sensitivity via STAT3/Myc related pathway in multidrug-resistant cancer cells. Scientific Reports. 9(1). 11628–11628. 14 indexed citations
14.
15.
Ling, Yong, Yu‐Ning Teng, Shi Chen, et al.. (2018). Development of novel amino-quinoline-5,8-dione derivatives as NAD(P)H:quinone oxidoreductase 1 (NQO1) inhibitors with potent antiproliferative activities. European Journal of Medicinal Chemistry. 154. 199–209. 31 indexed citations
16.
Teng, Yu‐Ning, Yingzi Wang, Pei‐Ling Hsu, et al.. (2018). Mechanism of action of cytotoxic compounds from the seeds of Euphorbia lathyris. Phytomedicine. 41. 62–66. 28 indexed citations
17.
Teng, Yu‐Ning, et al.. (2016). β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function. Phytomedicine. 23(3). 316–323. 52 indexed citations
18.
Teng, Yu‐Ning, et al.. (2016). Cordycepin re-sensitizes multidrug resistance cancer cells to chemotherapeutic agents through modulating P-glycoprotein expression and ATPase function. Journal of Functional Foods. 26. 681–690. 15 indexed citations
19.
Teng, Yu‐Ning, Yow‐Wen Hsieh, Chin‐Chuan Hung, & Hui‐Yi Lin. (2015). Demethoxycurcumin Modulates Human P-Glycoprotein Function via Uncompetitive Inhibition of ATPase Hydrolysis Activity. Journal of Agricultural and Food Chemistry. 63(3). 847–855. 32 indexed citations
20.
Hung, Chin‐Chuan, et al.. (2013). Functional Impact of ABCB1 Variants on Interactions between P-Glycoprotein and Methadone. PLoS ONE. 8(3). e59419–e59419. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sylwia Borska Breakdown of academic impact, for papers by Riham Salah El-Dine Breakdown of academic impact, for papers by Kee Wee Tan Breakdown of academic impact, for papers by Gowtham Kumar Subbaraj Breakdown of academic impact, for papers by Andrea Čumová Breakdown of academic impact, for papers by Narendra Joshi Breakdown of academic impact, for papers by Isabel Moreira da Silva Breakdown of academic impact, for papers by Yasmeen M. Attia Breakdown of academic impact, for papers by Yiyi Ye Breakdown of academic impact, for papers by Shu‐Yi Yin
Rankless by CCL
2026